Stock Screener App

무료 -

설치하다

13.08

0.38% -0.05

after-market

시간 외 거래: 13.08

쿨리난 온콜로지 (CGEM)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측

Cullinan Therapeutics Inc 주식(CGEM)의 최신 뉴스

Decliners Report: What is Cullinan Therapeutics Incs valuation compared to sector2026 PostEarnings & Target Return Focused Picks - baoquankhu1.vn

Rate Cut: Whats the RSI of Cullinan Therapeutics Inc stockMarket Activity Summary & Daily Chart Pattern Signal Reports - baoquankhu1.vn

Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

CGEM Earnings History & Surprises | EPS & Revenue Results | CULLINAN THERAPEUTICS INC (NASDAQ:CGEM) - ChartMill

Cullinan Therapeutics flags 2026 as “defining year” at Leerink, tees up key CLN-978/CLN-049 data - MarketBeat

Whale Trades: Can Cullinan Therapeutics Inc outperform under higher oil pricesDividend Hike & Free Safe Capital Growth Stock Tips - baoquankhu1.vn

Analysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (TLSI), Cullinan Management (CGEM) and Pfizer (PFE) - The Globe and Mail

Cullinan Therapeutics (NASDAQ:CGEM) Stock Price Expected to Rise, Wedbush Analyst Says - MarketBeat

Cullinan Therapeutics (CGEM): Wedbush Raises Price Target to $36 - GuruFocus

Cullinan Therapeutics Flags 2026 as Key Year for Clinical Data - Intellectia AI

CGEM: Key T-cell engager programs advance toward pivotal milestones and data readouts in 2026 - TradingView

Cullinan Therapeutics: Q4 Earnings InsightsCullinan Therapeutics (NASDAQ:CGEM) - Benzinga

CGEM: 2026 will be pivotal with key data and regulatory milestones for lead T-cell engager programs - TradingView

Cullinan Oncology (CGEM) Projects Strong Cash Position into 2029 - GuruFocus

Cullinan Therapeutics Reports 2025 Financial Results, Updates on CLN-978, Zipalertinib NDA, and 2026 Clinical Milestones - Minichart

Stifel raises Cullinan Oncology stock price target on autoimmune progress By Investing.com - Investing.com India

Cullinan Therapeutics Inc (CGEM) Reports Q4 Earnings - AlphaStreet

Stifel raises Cullinan Oncology stock price target on autoimmune progress - Investing.com

Cullinan Therapeutics (CGEM) Reports Q4 Loss of $0.77 Per Share, Flat Year-Over-Year - AlphaStreet

Cullinan Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com

Cullinan Therapeutics 2025 10-K: Advancing First-in-Class Therapies for Autoimmune Diseases and Cancer, Risks, and Strategic Developments - Minichart

Cullinan Therapeutics 2025 Financial Report: Q4 Loss Beats EstimatesNews and Statistics - IndexBox

Cullinan Therapeutics (CGEM) Anticipates Major Developments thro - GuruFocus

Cullinan Therapeutics: Fourth Quarter Earnings Overview - Bitget

Earnings Flash (CGEM) Cullinan Therapeutics Posts Q4 Net Loss $0.77 a Share, vs. FactSet Est of $0.77 Loss - marketscreener.com

Cullinan Therapeutics (NASDAQ:CGEM) Releases Earnings Results, Beats Expectations By $0.03 EPS - MarketBeat

Cullinan Therapeutics 10-K — $0 Revenue, Net Loss $219.9M - TradingView

CGEM: Robust cash reserves and advancing clinical pipeline position for multiple 2026 catalysts - TradingView

Cullinan Therapeutics: Q4 Earnings Snapshot - KTVB

Cullinan Therapeutics Q4 net loss widens - TradingView

Cullinan Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 ... - Bluefield Daily Telegraph

BRIEF-Cullinan Therapeutics Q4 Operating Expenses USD 55.259 Million - TradingView

Cullinan Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewswire

Jennifer Michaelson Sells 8,000 Shares of Cullinan Therapeutics (NASDAQ:CGEM) Stock - MarketBeat

Cullinan Therapeutics (CGEM) price target increased by 19.75% to 32.84 - MSN

Cullinan Therapeutics Maps 2026 Data Catalysts for Autoimmune CLN-978, AML CLN-049 at TD Cowen Conference - MarketBeat

Blue Owl Capital Holdings LP Has $14.89 Million Position in Cullinan Therapeutics, Inc. $CGEM - MarketBeat

What is Cullinan Therapeutics Incs valuation compared to sector2025 Biggest Moves & Precise Buy Zone Tips - baoquankhu1.vn

Can Cullinan Therapeutics Inc generate free cash flowWeekly Stock Recap & Smart Money Movement Tracker - baoquankhu1.vn

[SCHEDULE 13G] Cullinan Therapeutics, Inc. Passive Investment Disclosure (>5%) - Stock Titan

CGEM: Transformational milestones and pivotal data for autoimmune and AML programs expected by 2026 - TradingView

CGEM Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Cullinan Therapeutics (CGEM) Stock Analysis: Exploring A 101% Upside Potential - DirectorsTalk Interviews

Cullinan Therapeutics (NASDAQ:CGEM) Shares Up 7.6%Here's Why - MarketBeat

Cullinan Therapeutics executives to join major healthcare conference fireside chats - Traders Union

Cullinan Therapeutics (NASDAQ:CGEM) Insider Sells $25,169.20 in Stock - MarketBeat

Insider Sell: Jennifer Michaelson Sells Shares of Cullinan Thera - GuruFocus

Cullinan Therapeutics (CGEM) CSO sells 1,780 shares in Rule 10b5-1 trade - Stock Titan

CGEM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Cullinan Therapeutics (NASDAQ:CGEM) Insider Jennifer Michaelson Sells 1,752 Shares - MarketBeat

Insider Selling: Cullinan Therapeutics (NASDAQ:CGEM) Insider Sells 3,601 Shares of Stock - MarketBeat

Insider Selling: Cullinan Therapeutics (NASDAQ:CGEM) Insider Sells $66,301.54 in Stock - MarketBeat

Cullinan Therapeutics (NASDAQ:CGEM) CEO Nadim Ahmed Sells 13,515 Shares - MarketBeat

Cullinan Therapeutics (CGEM) CSO sells 5,353 shares under 10b5-1 plan - Stock Titan

Cullinan Therapeutics (CGEM) CMO sells shares to cover RSU tax bill - Stock Titan

[Form 4] Cullinan Therapeutics, Inc. Insider Trading Activity - Stock Titan

Jennifer Michaelson sells shares under 10b5-1 (CGEM) - Stock Titan

Cullinan Therapeutics (NASDAQ:CGEM) Hits New 12-Month HighWhat's Next? - MarketBeat

Cullinan Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire

Cullinan Therapeutics: Thesis Strengthening For T-Cell Engager Specialist (NASDAQ:CGEM) - Seeking Alpha

Jennifer Michaelson Sells 11,742 Shares of Cullinan Therapeutics (NASDAQ:CGEM) Stock - MarketBeat

Cullinan Therapeutics (NASDAQ:CGEM) Insider Jeffrey Alan Jones Sells 4,982 Shares - MarketBeat

RVMD

$99.29

1.20%

ROIV

$27.80

0.00%

MRNA

$52.37

0.06%

BNTX

$89.31

0.77%

INSM

$144.00

0.91%

ONC

$282.72

0.15%

야후에서 열기 | 구글에서 열기 | 핀비즈에서 열기 | MarketWatch에서 열기 | EDGAR에서 열기 | 로이터에서 공개